This company specializes in advanced metabolomics services to analyze small molecule profiles in biological samples. They provide comprehensive data interpretation and biomarker discovery to support pharmaceutical and diagnostic research. Their platform delivers actionable insights into metabolic pathways for disease understanding and therapeutic development.
Funding
Funding not disclosed
Founders
Product
Problem
Cancer treatment decisions often rely on population-based data, which may not accurately reflect individual patient responses to specific drugs. This can lead to suboptimal drug and dose selection, potentially reducing treatment efficacy and increasing adverse effects. The lack of personalized approaches in oncology can result in delayed responses and increased healthcare costs.
Solution
Pyon Therapeutics is developing a platform for personalized medicine in oncology, leveraging artificial intelligence and pharmacometabolomics to optimize drug and dose selection for cancer patients. The company's approach involves analyzing a patient's unique metabolic profile to predict their response to different treatments. By integrating pharmacometabolomic data with patient outcome data, Pyon Therapeutics aims to provide clinicians with actionable insights to guide treatment decisions. This personalized approach has the potential to improve treatment efficacy, reduce adverse effects, and ultimately enhance patient outcomes in cancer care.
Target Audience
The primary target audience includes oncologists, hospitals, and pharmaceutical companies seeking to improve cancer treatment outcomes through personalized medicine approaches.
Features
- Proprietary companion diagnostic test, Pyonero, utilizing pharmacometabolomics to predict individual patient responses to cancer drugs.
- AI-driven platform integrating patient-specific metabolic profiles with clinical outcome data.
- LC-MS analysis services for small molecule identification and quantitation.
- Comprehensive support for targeted and untargeted metabolomics studies.
- Curated standard libraries covering microbial and mammalian analysis.
- Specialty chemicals and tools, including retention indexing standards and stable isotope labeled reference materials.